APA-Zitierstil (7. Ausg.)

Hübner, H., Kurbacher, C. M., Kuesters, G., Hartkopf, A. D., Lux, M. P., Huober, J., . . . Ettl, J. (2020). Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany. BMC cancer, 20, . https://doi.org/10.1186/s12885-020-07546-1

Chicago-Zitierstil (17. Ausg.)

Hübner, Hanna, et al. "Heregulin (HRG) Assessment for Clinical Trial Eligibility Testing in a Molecular Registry (PRAEGNANT) in Germany." BMC Cancer 20 (2020). https://doi.org/10.1186/s12885-020-07546-1.

MLA-Zitierstil (9. Ausg.)

Hübner, Hanna, et al. "Heregulin (HRG) Assessment for Clinical Trial Eligibility Testing in a Molecular Registry (PRAEGNANT) in Germany." BMC Cancer, vol. 20, 2020, https://doi.org/10.1186/s12885-020-07546-1.